Avoro Capital
New York City, New Yorkavorocapital.com
Overview
Avoro Capital is a global life sciences investment firm with a focus on supporting emerging biotechnology companies . The firm invests in companies ranging from pre-clinical to mature commercial stage, novel therapies . Avoro Capital Advisors LLC (“AVCAP”) is a Delaware limited liability company . AVCAP is managed and fully controlled by Dr. Behzad Aghazadeh .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Ethyreal Bio | Jun 2026 | Series B | Lead |
| Ethyreal Bio | Jan 2026 | Series B | Lead |
| Hemab Therapeutics | Oct 2025 | Series C | Co-investor |
| Ottimo Pharma | Dec 2024 | Series A | Lead |
| Hemab Therapeutics | Feb 2023 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
